As drug development programmes increasingly demand real-world data collection – are the current eCOA instruments fit for purpose?

Which innovations will change the landscape, what are the challenges and how might we overcome them?

In this webinar Chief Technology Officer at Cambridge Cognition – Ricky Dolphin – discusses the developments required to make eCOA instruments suitable for high-frequency testing, and how voice-based eCOA and AI could improve the depth of information that questionnaires and scales deliver.

During this webinar you will learn: 

How to use electronic systems to your advantage rather than just an analogue of pen-and-paper tasks
Which developments are required to make eCOA instruments suitable for high-frequency testing: from form factors to the patient experience 
Opportunities for voice-based eCOA and AI to improve the quality of information that questionnaires and scales deliver

Watch webinar: